Top insider buys and sells disclosed for Monday, July 27 By Investing.com
Investing.com reported notable US insider trades disclosed July 23-27. Buys included Oak Valley Bancorp (2,000 shares at $32.50), Metropolitan Bank (1,000 at $89.98), Energizer (120,000 shares about $2.47M), McCormick (1,100 at $50.21), and Greenwich LifeSciences (about $47k). Sells included Datadog directors and CEO (about $16.4M total) and Safety Insurance Group (38,835 shares for about $4.0M), plus United Therapeutics CEO sales about $5.0M each.
How this was made
The 30-second read
Why it matters
For traders, the actionable element is mainly positioning around upcoming events mentioned (notably Datadog’s Aug 6 earnings) and interpreting whether insider activity is likely conviction versus scheduled selling.
Market read
This is mostly sentiment and positioning information from SEC disclosures, not a new fundamental catalyst.
What to watch
The article does not provide post-trade changes in guidance, contracts, or litigation outcomes; valuation commentary (fair value/overvalued) is model-based and may not reflect fundamentals.
Background
The piece is a roundup of insider buys and sells disclosed for Monday, July 27, citing transaction sizes, prices, and in some cases 10b5-1 plan mechanics.
Ticker impact
Datadog directors and CEO sold large Class A blocks under 10b5-1 plans, while the article notes upcoming earnings on Aug 6.
Bias modestly negative into the Aug 6 earnings window, with volatility possible if results diverge from expectations.
The article provides specific Form 4-style sale sizes, execution windows, and explicitly flags the next earnings date, which can affect positioning.
United Therapeutics CEO Martine Rothblatt sold about 9,500 shares twice in late July under a 10b5-1 plan with option exercises.
Slight negative bias into the next catalyst cycle, with limited directional conviction without new fundamentals.
The article is detailed on transaction mechanics and prices, but it does not disclose new company-specific operating news beyond the sales.
Aqua Capital, a 10% owner and director, bought 120,000 Energizer shares across July 23-24 at $20.084 to $21.0866.
Potential support for the stock over days to weeks, but likely secondary to upcoming earnings and broader tape.
The article provides buy size and price range, but no new fundamental catalyst is disclosed.
McCormick director Michael Conway bought 1,100 shares of non-voting stock near the company’s 52-week low.
Limited impact; could slightly improve sentiment if the market is already stabilizing.
The text includes valuation and dividend streak context, but no new operational development.
Oak Valley Bancorp director Gary Strong bought 2,000 shares at $32.50 on July 27.
Negligible to mild positive bias, mostly for short-term sentiment.
The article gives transaction details but no new bank-specific news beyond the insider trade.
Market effects
Primarily company-specific sentiment signals; no clear sector-wide catalyst beyond general risk appetite around insider activity.
US-listed names only; limited cross-region impact implied.
Low, as the article is a US insider-trading roundup with no global macro or geopolitical trigger.
Counterpoint
Because many sales are explicitly under 10b5-1 plans, the market may overreact to insider selling signals that are mechanically scheduled rather than conviction-driven.
Key entities
- companyDatadog
Director and CEO sold sizable Class A shares under 10b5-1; earnings scheduled for Aug 6.
- companySafety Insurance Group
10% owner SRB Corp sold 38,835 shares near 52-week highs after a strong run.
- companyUnited Therapeutics
CEO Martine Rothblatt sold shares twice in late July under a 10b5-1 plan with option exercises.
